Mouth Disease

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Mouth Disease

Top of Directory » All Categories » by Illness » Mouth Disease



  • Prevention Chemotherapy Induced Mucositis by Zinc Sulfate

    Conditions:   Mucositis;   Bone Marrow Transplantation
    Interventions:   Drug: Zinc Sulfate;   Drug: Placebo
    Sponsors:   Tehran University of Medical Sciences;   Hematology-Oncology and Stem Cell Transplantation Research Center
    Recruiting - verified November 2009
  • A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)

    Condition:   Periodontitis
    Intervention:   Drug: Trafermin
    Sponsor:   Kaken Pharmaceutical
    Not yet recruiting - verified November 2009
  • Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome

    Condition:   Sjögren's Syndrome
    Intervention:   Drug: LimphoStat-B
    Sponsors:   University of Udine;   Azienda Ospedaliera S. Maria della Misericordia
    Recruiting - verified November 2009
  • Low-energy Laser Therapy for Prevention of Oral Mucositis in Children

    Condition:   Oral Mucositis
    Intervention:   Device: LLLT :low level laser therapy
    Sponsors:   University Hospital, Clermont-Ferrand;   - Centre Régional de Cancérologie et Thérapie Cellulaire Pédiatrique, CHU de Clermont-Ferrand;   - Faculté de chirurgie dentaire, Clermont-Ferrand;   - Centre de Pharmacologie Clinique, INSERM CIC 501;   - Laboratoire des Matériaux Inorganiques, ESA CNRS 6002 et ENSCCF, Université Blaise-Pascal, Aubière
    Recruiting - verified November 2009
  • Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation

    Condition:   Oral Complications
    Intervention:   Procedure: management of therapy complications
    Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)
    Active, not recruiting - verified February 2002
  • Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

    Condition:   Inflammatory Bowel Disease
    Interventions:   Drug: Monofer;   Drug: Iron Sulphate
    Sponsors:   Pharmacosmos A/S;   Max Neeman International
    Recruiting - verified November 2009
  • Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease

    Conditions:   Nonalcoholic Steatohepatitis;   Fatty Liver Disease
    Intervention:   Dietary Supplement: Bovine colostrum powder
    Sponsor:   Hadassah Medical Organization
    Recruiting - verified November 2009
  • Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

    Condition:   Peptic Ulcer Disease
    Interventions:   Drug: Esomeprazole/ASA Fixed Combination;   Drug: Esomeprazole;   Drug: ASA
    Sponsor:   AstraZeneca
    Not yet recruiting - verified November 2009
  • Efficacy Study of T2 Versus AZA to Maintain Clinical and Endoscopic Remission in Postoperative Crohn's Disease

    Condition:   Crohn's Disease
    Interventions:   Drug: T2;   Drug: Azathioprine
    Sponsor:   Jinling Hospital, China
    Active, not recruiting - verified November 2009
  • Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: Infliximab plus methotrexate versus methotrexate alone;   Drug: Infliximab plus methotrexate versus Combination of DMARDs;   Drug: Combination of DMARDs versus Methotrexate alone
    Sponsors:   Helsinki University Central Hospital;   Foundation for Pediatric Research, Finland;   Päivikki and Sakari Sohlberg Foundation, Finland;   Rheumatism Foundation Hospital;   Scandinavian Rheumatology Research Foundation;   Paijat-Hame Hospital District
    Active, not recruiting - verified November 2009
  • A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

    Conditions:   Chronic Kidney Disease;   Renal Dialysis;   Renal Insufficiency
    Intervention:   Drug: ASP1585
    Sponsor:   Astellas Pharma Inc
    Not yet recruiting - verified November 2009
  • Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma

    Condition:   Hodgkins Lymphoma
    Interventions:   Drug: 8 cycles BEACOPPesc plus oral contraceptive;   Drug: 8 cycles BEACOPPesc plus Goserelin
    Sponsor:   University of Cologne
    Terminated - verified November 2009
  • Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

    Conditions:   Coronary Artery Disease;   Chronic Kidney Disease;   Hypovitaminosis D;   Secondary Hyperparathyroidism
    Interventions:   Drug: paricalcitol;   Drug: placebo
    Sponsors:   Thomas Jefferson University;   Abbott
    Recruiting - verified November 2009
  • Panitumumab and Irinotecan for Malignant Gliomas

    Condition:   Recurrent Grade IV Malignant Glioma
    Intervention:   Drug: Panitumumab in Combination with Irinotecan
    Sponsors:   Duke University;   Amgen
    Not yet recruiting - verified November 2009
  • Safety and Efficacy of BMS-790052 Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin)

    Condition:   Hepatitis C Infection
    Interventions:   Drug: BMS-790052;   Drug: BMS-790052;   Drug: Placebo;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
    Sponsor:   Bristol-Myers Squibb
    Not yet recruiting - verified November 2009
  • Safety and Efficacy of BMS-790052 Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2b and Ribavirin)

    Condition:   Hepatitis C Infection
    Interventions:   Drug: BMS-790052;   Drug: BMS-790052;   Drug: Placebo;   Drug: Peginterferon alfa-2b;   Drug: Ribavirin
    Sponsor:   Bristol-Myers Squibb
    Not yet recruiting - verified November 2009
  • A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction

    Condition:   Acute Coronary Syndromes
    Interventions:   Drug: Placebo;   Drug: Prasugrel
    Sponsors:   Eli Lilly and Company;   Daiichi Sankyo Co., Ltd.
    Not yet recruiting - verified November 2009
  • Study of Oral Arsenic Trioxide With or Without Ascorbic Acid in Adults With Myelofibrosis

    Condition:   Primary Myelofibrosis
    Intervention:   Drug: Dose Escalating Arsenic Trioxide plus ascorbic Acid
    Sponsors:   Roswell Park Cancer Institute;   Cephalon
    Not yet recruiting - verified November 2009
  • Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata

    Condition:   Alopecia Areata
    Interventions:   Device: Subcutaneous injection luer syringe;   Device: DERMOJET (a syringe without a needle)
    Sponsor:   Sheba Medical Center
    Not yet recruiting - verified November 2009
  • Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung

    Conditions:   Cancer Survivor;   Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer;   Precancerous/Nonmalignant Condition
    Interventions:   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study
    Sponsors:   Robert H. Lurie Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified November 2009
  • Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

    Conditions:   Bladder Cancer;   Breast Cancer;   Head and Neck Cancer;   Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: docetaxel;   Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Active, not recruiting - verified November 2009
  • Influence of Vitamin D Treatment on Multi-systemic Functions in Young Men With Vitamin D Deficiency Due to Work Conditions

    Condition:   Vitamin D Deficiency
    Interventions:   Dietary Supplement: Vitamin D;   Dietary Supplement: Placebo
    Sponsors:   Rambam Health Care Campus;   Ministry of Labour and Social Affairs, Israel
    Recruiting - verified November 2009
  • Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists

    Condition:   Idiopathic Parkinson's Disease
    Interventions:   Drug: piribedil;   Drug: pramipexole or ropinirole
    Sponsors:   Desitin Arzneimittel GmbH;   FGK Clinical Research GmbH
    Not yet recruiting - verified November 2009
  • A Study of CellCept (Mycophenolate Mofetil) in Lung Transplant Recipients

    Condition:   Lung Transplantation
    Intervention:   Drug: mycophenolate mofetil [CellCept]
    Sponsor:   Hoffmann-La Roche
    Not yet recruiting - verified November 2009
  • A Safety/Proof of Concept Study to Evaluate the Effects of Oral QLT091001 in Children With Leber Congenital Amaurosis (LCA)

    Condition:   Visual Impairment Due to Leber Congenital Amaurosis (LCA)
    Intervention:   Drug: QLT091001
    Sponsor:   QLT Inc
    Recruiting - verified November 2009
  • Unrelated Double Umbilical Cord Blood Units Transplantation

    Conditions:   Leukemia, Myeloid, Acute;   Leukemia, Lymphoblastic, Acute;   Leukemia, Myeloid, Chronic
    Intervention:   Drug: Stem cell Transplantation
    Sponsors:   Tehran University of Medical Sciences;   Hematology-Oncology and Stem Cell Transplantation Research Center
    Recruiting - verified November 2009
  • Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

    Conditions:   Coronary Artery Disease;   Hydroxymethylglutaryl-CoA Reductase Inhibitors;   Atherosclerosis;   Oxidative Stress;   Endothelium
    Interventions:   Drug: Atorvastatin, high vs low dose;   Drug: Atorvastatin vs Placebo
    Sponsor:   Hippocration General Hospital
    Recruiting - verified November 2009
  • Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By Chemotherapy With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery

    Condition:   Pancreatic Cancer
    Interventions:   Drug: capecitabine;   Drug: erlotinib hydrochloride;   Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
    Sponsors:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)
    Not yet recruiting - verified November 2009
  • A Study of RO5072759 With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009
  • Do Antibiotics Prevent Anal Fistulae Formation?

    Condition:   Anal Fistula
    Interventions:   Drug: Amoxicillin-Clavulanate;   Drug: Placebo
    Sponsor:   Ankara University
    Completed - verified November 2009
  • FOSCO Study (Functional Outcomes Study of OROS (Osmotic-controlled Release Oral Delivery System) Methylphenidate

    Condition:   Attention Deficit Disorder With Hyperactivity
    Intervention:   Drug: OROS methylphenidate hydrochloride
    Sponsor:   Janssen Korea, Ltd., Korea
    Completed - verified November 2009
  • A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus

    Condition:   Onychomycosis
    Interventions:   Drug: Albaconozole;   Drug: Placebo;   Drug: Albaconozole;   Drug: Placebo;   Drug: Albaconozole;   Drug: Placebo
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009
  • Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research

    Conditions:   Breast Cancer;   Heart Failure
    Intervention:   Drug: perindopril (or placebo) OR bisoprolol (or placebo) OR both perindopril and bisoprolol OR placebo
    Sponsor:   University of Alberta
    Not yet recruiting - verified November 2009
  • Gefitinib 500mg Versus 250mg in Patients With Non-Small Cell Lung Cancer (NSCLC) With Stable Disease After a Month Treatment of Gefitinib 250mg

    Condition:   Non-small Cell Lung Cancer
    Intervention:   Drug: Gefitinib 500mg/Gefitinib 250mg
    Sponsors:   Sun Yat-sen University;   AstraZeneca
    Recruiting - verified November 2009
  • Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

    Condition:   Metastatic Melanoma
    Interventions:   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Everolimus
    Sponsors:   Sarah Cannon Research Institute;   Novartis
    Not yet recruiting - verified November 2009
  • Study of Ataluren (PTC124®) in Nonambulatory Patients With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)

    Conditions:   Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy
    Intervention:   Drug: Ataluren (PTC124)
    Sponsors:   PTC Therapeutics;   Genzyme
    Not yet recruiting - verified November 2009
  • Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

    Condition:   Thymic Carcinoma
    Intervention:   Drug: PHA-848125AC
    Sponsor:   Nerviano Medical Sciences
    Not yet recruiting - verified November 2009
  • The Effect of Exposure to Maternal Human Milk Odor on Physiological State of Preterms.

    Conditions:   Health Preterm Infants With no Active Disease;   Human Milk Nutrition;   Incubator Stay
    Intervention:   Other: adding pad with maternal milk in hte incubator
    Sponsors:   Sheba Medical Center;   Tel Aviv University
    Not yet recruiting - verified November 2009
  • Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder

    Conditions:   Smoking Cessation;   Bipolar Disorder
    Interventions:   Drug: Varenicline (Chantix);   Drug: Placebo
    Sponsors:   University of Pittsburgh;   National Institute of Mental Health (NIMH);   Pfizer
    Not yet recruiting - verified November 2009
  • Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

    Conditions:   Brain Cancer;   Choroid Plexus Tumors
    Interventions:   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Dactinomycin;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Irinotecan;   Drug: Leucovorin;   Drug: Methotrexate;   Drug: Temozolomide;   Drug: Vincristine
    Sponsor:   M.D. Anderson Cancer Center
    Recruiting - verified November 2009
  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Effect of SRT2104 on Endotoxin-induced Inflammation

    Condition:   Sepsis
    Interventions:   Drug: SRT2104;   Drug: Placebo
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Metabolic Effects of Paricalcitol

    Condition:   Chronic Kidney Disease
    Interventions:   Drug: Paricalcitol;   Drug: Placebo
    Sponsors:   University of Washington;   Abbott
    Recruiting - verified October 2009
  • Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo

    Condition:   Vitiligo
    Intervention:   Dietary Supplement: GINGKO BILOBA
    Sponsors:   King Saud University;   University Hospital
    Recruiting - verified November 2009
  • Efficacy, Safety, Tolerability and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices

    Condition:   Asthma
    Interventions:   Drug: QAB149 placebo;   Drug: QAB149;   Drug: QAB149;   Drug: QAB149
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009
  • Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections

    Condition:   Urinary Tract Infection
    Interventions:   Drug: ertapenem sodium;   Drug: Comparator: ceftriaxone sodium
    Sponsor:   Merck
    Completed - verified November 2009
  • Efficacy of Gabapentin or Amitriptyline to Reduce Postoperative Pain After Lumbar Laminectomy and Diskectomy

    Conditions:   Herniated Disc;   Intervertebral Disc Displacement
    Intervention:   Drug: Gabapentin , Amitriptyline
    Sponsor:   Tabriz University
    Recruiting - verified November 2009
  • Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age

    Conditions:   Chronic Lymphocytic Leukemia;   Leukemia
    Intervention:   Drug: lenalidomide
    Sponsors:   Memorial Sloan-Kettering Cancer Center;   Celgene Corporation
    Recruiting - verified November 2009
  • Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

    Conditions:   Breast Cancer;   Lung Cancer;   Colon Cancer;   Pancreatic Cancer;   Head and Neck Cancer;   Kidney Cancer;   Sarcoma;   Hepatocellular Cancer
    Interventions:   Drug: Pazopanib;   Drug: Pazopanib;   Drug: Ixabepilone;   Drug: Ixabepilone;   Drug: Ixabepilone
    Sponsors:   Masonic Cancer Center, University of Minnesota;   GlaxoSmithKline;   Bristol-Myers Squibb
    Recruiting - verified November 2009
  • The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis

    Condition:   Lupus Nephritis
    Interventions:   Drug: mycophenolate sodium;   Drug: cyclophosphamide
    Sponsors:   Chulalongkorn University;   Clinical Research Collaborative Network;   Health Intervention and Technology Assessment Program (HITAP)
    Not yet recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials